The most common molecular markers for lung adenocarcinoma are epidermal growth factor receptor (EGFR) and Kirsten ras (KRAS), both of which may occur in nearly 30% of all cases (Testa, Castelli & Pelosi, 2018). This evidence concerns the gene EGFR and lung adenocarcinoma.